إعلان
إعلان

MDCX

MDCX logo

Medicus Pharma Ltd. Common Stock

1.58
USD
برعاية
+0.01
+0.57%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

1.64

+0.06
+3.86%

تقارير أرباح MDCX

النسبة الإيجابية المفاجئة

MDCX تفوق 2 من 8 آخر التقديرات.

25%

التقرير التالي

بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.11
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-83.08%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-38.89%

Medicus Pharma Ltd. Common Stock earnings per share and revenue

On ١٤ نوفمبر ٢٠٢٥, MDCX reported earnings of -0.65 USD per share (EPS) for Q3 25, missing the estimate of -0.29 USD, resulting in a -119.74% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.55% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an نقصان of -83.08% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Medicus Pharma Ltd. Common Stock reported EPS of -$0.65, missing estimates by -119.74%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.55%, changed from $2.20 before the earnings release to $2.30 the day after.
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
Based on 6 المحللين, Medicus Pharma Ltd. Common Stock is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان